- Home
- PCLA vs DARE Comparison
PCLA vs DARE Comparison
Compare PCLA & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- DARE
- Stock Information
- Founded
- PCLA 2008
- DARE 2015
- Country
- PCLA Japan
- DARE United States
- Employees
- PCLA N/A
- DARE N/A
- Industry
- PCLA Building Products
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- PCLA Consumer Discretionary
- DARE Health Care
- Exchange
- PCLA Nasdaq
- DARE Nasdaq
- Market Cap
- PCLA 32.3M
- DARE 26.3M
- IPO Year
- PCLA 2025
- DARE N/A
- Fundamental
- Price
- PCLA $2.48
- DARE $2.44
- Analyst Decision
- PCLA
- DARE Strong Buy
- Analyst Count
- PCLA 0
- DARE 3
- Target Price
- PCLA N/A
- DARE $12.50
- AVG Volume (30 Days)
- PCLA 2.4M
- DARE 38.9K
- Earning Date
- PCLA 01-01-0001
- DARE 08-11-2025
- Dividend Yield
- PCLA N/A
- DARE N/A
- EPS Growth
- PCLA N/A
- DARE N/A
- EPS
- PCLA N/A
- DARE N/A
- Revenue
- PCLA $5,475,228.00
- DARE $25,909.00
- Revenue This Year
- PCLA N/A
- DARE $99,756.91
- Revenue Next Year
- PCLA N/A
- DARE $119.77
- P/E Ratio
- PCLA N/A
- DARE N/A
- Revenue Growth
- PCLA 40.19
- DARE N/A
- 52 Week Low
- PCLA $0.37
- DARE $2.35
- 52 Week High
- PCLA $9.80
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- PCLA N/A
- DARE 35.15
- Support Level
- PCLA N/A
- DARE $2.37
- Resistance Level
- PCLA N/A
- DARE $2.54
- Average True Range (ATR)
- PCLA 0.00
- DARE 0.11
- MACD
- PCLA 0.00
- DARE -0.02
- Stochastic Oscillator
- PCLA 0.00
- DARE 17.50
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.